Investors reacted positively to news that the company was using a $50 million private placement to help fund a Phase 3 study.
Presented at the European Society for Medical Oncology, study results showed Datroway extended survival in breast cancer ...
A closely watched trial in Chinese patients is raising hope that ivonescimab will outperform Keytruda in a large global study ...
Some on Wall Street weren’t too impressed with results from a pivotal trial that tested an Exelixis drug, zanzalintinib, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback